Biblioteca Virtuale per la Salute – Piemonte – "Le biblioteche non si fanno…crescono" A. Birrell

Sfoglia per AUTORE
BRUNO B
Collezione AOU Città della Salute di Torino

Items : 143

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. in British journal of haematology / Br J Haematol. 2025 Mar;206(3):924-929. doi: 10.1111/bjh.19976. Epub 2025 Jan 7.

2025
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Vitale C; Coscia M; Bruno B; Rambaldi A; Laurenti L; Krampera M; Gaidano G; Rivela P; Quaglia FM; Quaresmini G; Moia R; Innocenti I; Deodato M; Frustaci AM; Catania G; Montalbano MC; Perutelli F; Boccellato E;

Influence of ESBL colonization status on gut microbiota composition during allogenic hematopoietic stem cell transplantation. in Scientific reports / Sci Rep. 2025 Jan 8;15(1):1275. doi: 10.1038/s41598-025-85128-6.

2025
AOU Città della Salute di Torino

Corcione S; Ferrocino I; Lupia T; Busca A; Bianco G; Dellacasa C; Giaccone L; Brunello L; Butera S; Costa C; Bruno B; De Rosa FG;

Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial. in Blood advances / Blood Adv. 2025 Jan 14:bloodadvances.2024014948. doi: 10.1182/bloodadvances.2024014948.

2025
AOU Alessandria
AOU Città della Salute di Torino

da Silva MG; Zilioli VRR; Balzarotti M MD; Boccomini C; Postorino M; Merli M; Careddu MG; Lucchini E; Patti C; Palmas AD; Pascarella A; Michieli M; Vallisa D; Puccini B; Ballerini F; Stefoni V Dr; Cavallo F; Amaducci E; Evangelista A; Civita AM; Alessandria B; Gandossini M; Genuardi E; Ragaini S; Galli A; Bruno B; Rizzo E; Ladetto M; Malcovati L; et alii...

Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor. in Bone marrow transplantation / Bone Marrow Transplant. 2025 Jan;60(1):79-82. doi: 10.1038/s41409-024-02432-x. Epub 2024 Oct 4.

2025
AOU Città della Salute di Torino

Bringhen S; Santoro A; Bruno B; Lorenzi M; Francisci T; Benevolo G; De Philippis C; Mannina D; Larocca A; Taurino D; Oliva S; D'agostino M; Mariotti J; Mercadante S; Gay F; Sarina B; Casson A; Garibaldi B; Bertuglia G; Mina R; Bramanti S;

M-protein-related necrobiotic granuloma in a multiple myeloma patient treated with daratumumab, lenalidomide and dexamethasone. in British journal of haematology / Br J Haematol. 2025 Jan;206(1):16-17. doi: 10.1111/bjh.19887. Epub 2024 Nov 14.

2025
AOU Città della Salute di Torino

D'Agostino M; Impalà GA; Bruno B; Bringhen S; Bertuglia G;

Post Transplant Cyclophosphamide as GvHD Prophylaxis in Patients Receiving Mismatched Unrelated HCT: the PHYLOS trial. in Blood advances / Blood Adv. 2025 Feb 10:bloodadvances.2024015173. doi: 10.1182/bloodadvances.2024015173.

2025
AOU Città della Salute di Torino

Raiola A; Bruno B; Risitano AM; Mosna F Dr; Cavattoni IM; Onida F; Saporiti GN; Patriarca F; Battista ML; Pavone V; Mele A MD; Chiusolo P; Sica S; Loteta B; di Grazia C; Carella AM; Salvatore D; Morello E; Leoni A; Giaccone L; Bernasconi P; Terruzzi E; Mordini N; Borghero C; Zallio F; Luppi M; Grassi A; Olivieri A; Piras E; et alii...

Risk of Infection in Patients With Multiple Myeloma Treated With T-Cell Redirecting Approaches: A Call Out for Clinicians. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2024 Sep;24(9):592-603. doi: 10.1016/j.clml.2024.05.002. Epub 2024 May 4

2024
AOU Città della Salute di Torino

Mina R; Corcione S; Mikulska M; Bruno B; De Rosa FG; Bringhen S; Lupia T; Cani L;

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia: Results of a Single-Center Study. in Hematology reports / Hematol Rep. 2024 Oct 17;16(4):636-647. doi: 10.3390/hematolrep16040062.

2024
AOU Città della Salute di Torino

Stella D; Gill J; Passera R; Zompi S; Dellacasa CM; Audisio E; Cerrano M; Dogliotti I; Dicataldo M; Secreto C; Bruno B; Freilone R; Busca A; Giaccone L;

A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents. in Haematologica / Haematologica. 2024 May 1;109(5):1525-1534. doi: 10.3324/haematol.2023.284023.

2024
AOU Città della Salute di Torino

Mina R; Petrucci MT; Bonello F; Bongarzoni V; Saccardi R; Bertuglia G; Mengarelli A; Spadaro A; Lisi C; Curci P; Lemoli RM; Ballanti S; Floris R; Cupelli L; Tosi P; Olivieri A; Rota-Scalabrini D; Cangialosi C; Nozzoli C; Anaclerico B; Fazio F; Bruno B; Mancuso K; Corradini P; Milone G; Boccadoro M;

Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells. in Blood cancer journal / Blood Cancer J. 2024 Jun 7;14(1):94. doi: 10.1038/s41408-024-01075-x.

2024
AOU Alessandria
AOU Città della Salute di Torino

Bruno B; Zamagni E; Stefanoni P; Palmieri S; Liberati AM; Monaco F; Annibali O; Galieni P; Garzia M; Olivero M; Rogers J; Ruggeri M; Pescosta N; Pisani F; Tosi P; Pascarella A; Pietrantuono G; Arigoni M; De Sabbata G; Bertamini L; Belotti A; Rota-Scalabrini D; D'Agostino M; Calogero RA; Boccadoro M; Musto P; Gay F;

Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial. in Scientific reports / Sci Rep. 2024 Jul 23;14(1):16946. doi: 10.1038/s41598-024-67906-w.

2024
AOU Alessandria
AOU Città della Salute di Torino

Pavone V; Castellino C; Mian M; Re F; Galimberti S; Usai SV; Olivieri J; Gaidano G; Tani M; Stelitano C; Carella AM; Musuraca G; Hohaus S; Cavallo F; Tavarozzi R; Ragaini S; Genuardi E; Zaccaria GM; Alessandria B; Ferrero S; Clerico M; Evangelista A; Bruno B; Cortelazzo S; Passera R; Ladetto M;

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma. in Blood cancer journal / Blood Cancer J. 2024 Jul 19;14(1):117. doi: 10.1038/s41408-024-01096-6.

2024
AOU Città della Salute di Torino

Ziccheddu B; Giannotta C; D'Agostino M; Bertuglia G; Saraci E; Oliva S; Genuardi E; Papadimitriou M; Diamond B; Corradini P; Coffey D; Landgren O; Bolli N; Bruno B; Boccadoro M; Massaia M; Maura F; Larocca A;

Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study. in Cancer medicine / Cancer Med. 2024 Jul;13(14):e7448. doi: 10.1002/cam4.7448.

2024
AO Cuneo
AOU Città della Salute di Torino

Freilone R; Ferrero S; Bondielli G; Lonardo A; Consoli C; Mortara U; Molinaro L; Ghislieri M; Novo M; Levis M; Botto B; Ragaini S; Mercadante S; Musto D; Vassallo F; Clerico M; Peri V; Dogliotti I; Ricardi U; Bruno B; Cavallo F;

An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. in American journal of hematology / Am J Hematol. 2024 Jan;99(1):137-141. doi: 10.1002/ajh.27147. Epub 2023 Nov 20.

2024
AOU Città della Salute di Torino

Bruno B; Maletta F; Bringhen S; Benevolo G; Bertuglia G;

Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience. in Leukemia research / Leuk Res. 2024 Jan;136:107421. doi: 10.1016/j.leukres.2023.107421. Epub 2023 Nov 18.

2024
AOU Città della Salute di Torino

Ferrero D; Dellacasa CM; Busca A; Giaccone L; Lanzarone G; Bruno B; Freilone R; Giai V; Frairia C; D'Ardia S; Catania FM; Boscaro E; Arrigo G; Olivi M; Apolito V; Urbino I; Secreto C; Audisio E; Cerrano M;

Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. in Cancers / Cancers (Basel). 2024 Feb 21;16(5):865. doi: 10.3390/cancers16050865.

2024
AOU Città della Salute di Torino

Ricardi U; Giaccone L; Bruno B; Cerrano M; Maffini E; Cavallin C; Felicetti F; Bartoncini S; Martin A; Levis M; Dogliotti I;

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma. in Blood / Blood. 2024 Feb 15;143(7):592-596. doi: 10.1182/blood.2023022080.

2024
AOU Città della Salute di Torino

Paris L; Zambello R; Mancuso K; Gamberi B; Palmas AD; Gozzetti A; Cellini C; Ballanti S; Velluti C; Vincelli ID; Ronconi S; Pavone V; Grasso M; Ledda A; Oliva S; Corradini P; Morè S; Belotti A; Rota-Scalabrini D; Bertuglia G; D'Agostino M; Petrucci MT; Bruno B; Musto P; Gay F;

Multiple Myeloma.

2024
AOU Città della Salute di Torino

Mateos MV; Gagelmann N; Bruno B; Mohty M;

Impact of allogeneic stem cell transplantation on thyroid function. in Journal of endocrinological investigation / J Endocrinol Invest. 2023 Sep;46(9):1825-1834. doi: 10.1007/s40618-023-02039-x. Epub 2023 Mar 8.

2023
AOU Città della Salute di Torino

Giaccone L; Busca A; Dellacasa C; Dionisi-Vici M; Gill J; Leone S; Marinelli L; Fortunati N; Zavattaro M; Rosso D; Faraci D; Gatti F; Felicetti F; Arvat E; Bruno B; Brignardello E;

Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia. in Scientific reports / Sci Rep. 2023 Oct 7;13(1):16950. doi: 10.1038/s41598-023-44039-0.

2023
AOU Città della Salute di Torino

Vitale C; Griggio V; Todaro M; Riganti C; Jones R; Boccellato E; Perutelli F; Arruga F; Vaisitti T; Efremov DG; Deaglio S; Landesman Y; Bruno B; Coscia M;

Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Oct 2;29(19):3901-3913. doi: 10.1158/1078-0432.CCR-22-3209.

2023
AOU Città della Salute di Torino

Boyle EM; Blaney P; Stoeckle JH; Wang Y; Ghamlouch H; Gagler D; Braunstein M; Williams L; Tenenbaum A; Siegel A; Chen X; Varma G; Avigan J; Li A; Jinsi M; Kaminetzsky D; Arbini A; Montes L; Corre J; Rustad EH; Landgren O; Maura F; Walker BA; Bauer M; Bruno B; Tsirigos A; Davies FE; Morgan GJ;

Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax. in British journal of haematology / Br J Haematol. 2023 Nov;203(4):e98-e101. doi: 10.1111/bjh.19022. Epub 2023 Aug 2.

2023
AOU Città della Salute di Torino

D'Ardia S; Frairia C; Audisio E; Beggiato E; Lanzarone G; Freilone R; Bruno B; Gravetti A; Copia C; De Simone MC; Di Biase F; Secreto C; Giai V; Perrone S; Olivi M; Vasseur L; Apolito V; Arrigo G; Ferrero D; Cerrano M; Ferrara F;

New Strategies for the Treatment of Older Myeloma Patients. in Cancers / Cancers (Basel). 2023 May 10;15(10):2693. doi: 10.3390/cancers15102693.

2023
AOU Città della Salute di Torino

Larocca A; Cani L; Bertuglia G; Bruno B; Bringhen S;

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study. in Transplantation direct / Transplant Direct. 2023 Feb 22;9(3):e1451. doi: 10.1097/TXD.0000000000001451. eCollection 2023 Mar.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Proia A; Carluccio P; Borghero C; Pavone V; Skert C; Iori AP; Luppi M; Vacca A; Falcioni S; Onida F; Bassi S; Mazza P; Nozzoli C; Maffini E; Casini M; Chiusolo P; Carella AM; Olivieri A; Terruzzi E; Natale A; De Gobbi M; Bernasconi P; Bramanti S; Grillo G; Giaccone L; Bruno B; Patriarca F; Martino M; Polverelli N; et alii...

Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges. in Current treatment options in oncology / Curr Treat Options Oncol. 2023 Jun;24(6):693-710. doi: 10.1007/s11864-023-01089-w. Epub 2023 Apr 26.

2023
AOU Città della Salute di Torino

Olivi M; Di Biase F; Lanzarone G; Arrigo G; Martella F; Apolito V; Secreto C; Freilone R; Bruno B; Audisio E; Ferrero D; Beggiato E; Cerrano M;

Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102016. doi: 10.1016/j.eclinm.2023.102016. eCollection 2023 Jun.

2023
AOU Città della Salute di Torino

Oliva S; Genuardi E; Paris L; D'Agostino M; Rogers J; Rota-Scalabrini D; Jacob AP; Patriarca F; Luppi M; Bertazzoni P; Velluti C; Capra A; Saraci E; Rossi M; Allegra A; Mina R; Gentile M; Kirsch IR; Belotti A; Cavo M; Bruno B; Musto P; Boccadoro M; Zamagni E; Gay F;

Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review. in Journal of clinical medicine / J Clin Med. 2023 Jul 10;12(14):4590. doi: 10.3390/jcm12144590.

2023
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Porreca A; Grimaldi D; Massaia M; Valpreda A; Dainese C; Valeri F; Bardetta M; Sella C; Borchiellini A;

Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. in Cancers / Cancers (Basel). 2023 Dec 21;16(1):46. doi: 10.3390/cancers16010046.

2023
AOU Città della Salute di Torino

Benevolo Savelli C; Clerico M; Botto B; Secreto C; Cavallo F; Dellacasa C; Busca A; Bruno B; Freilone R; Cerrano M; Novo M;

Anti-ADAMTS13 Autoantibodies: From Pathophysiology to Prognostic Impact-A Review for Clinicians. in Journal of clinical medicine / J Clin Med. 2023 Aug 29;12(17):5630. doi: 10.3390/jcm12175630.

2023
AOU Città della Salute di Torino

Dainese C; Valeri F; Bruno B; Borchiellini A;

Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera. in Vascular health and risk management / Vasc Health Risk Manag. 2023 Nov 22;19:765-778. doi: 10.2147/VHRM.S429995. eCollection 2023.

2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Milan A; Bruno B; Rapezzi D; Biolé CA; Sartori C; Beggiato E; Marchetti M; Melchio R; Benevolo G;

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Sep;57(9):1421-1427. doi: 10.1038/s41409-022-01674-x. Epub 2022 Jun 25.

2022
AOU Città della Salute di Torino

Neubauer A; Avenoso D; Yakoub-Agha I; Arroyo H; Bay JO; Olivieri A; Vrhovac R; Charbonnier A; Bruno B; Bug G; Stölzel F; Martino M; Chalandon Y; Socié G; Castagna L; Pavlu J; Raiola AM; Blaise D; Labopin M; Galimard JE; Devillier R; Nguyen S; Forcade E; Brissot E; Savani B; Nagler A; Mohty M;

Impact of COVID-19 Infection, Vaccination, and Serological Response in Immune Thrombocytopenic Purpura Patients: A Single-Center Global Analysis. in Biomedicines / Biomedicines. 2022 Oct 23;10(11):2674. doi: 10.3390/biomedicines10112674.

2022
AOU Città della Salute di Torino

Dainese C; Valeri F; Bardetta M; Sella C; Porreca A; Valpreda A; Pittaluga F; Mengozzi G; Bruno B; Borchiellini A;

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors. in Cancers / Cancers (Basel). 2022 Oct 18;14(20):5108. doi: 10.3390/cancers14205108.

2022
AOU Città della Salute di Torino

Boccalatte F; Mina R; Aroldi A; Leone S; Suryadevara CM; Placantonakis DG; Bruno B;

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug

2022
AOU Città della Salute di Torino

Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 May;28(5):258.e1-258.e8. doi: 10.1016/j.jtct.2022.01.026. Epub 2022 Feb 4

2022
AOU Città della Salute di Torino

Gahrton G; García-Cadenas I; Reguera JL; López-Corral L; Nahi H; Granell M; Einsele H; Bruno B; Fanin R; Herrera P; Patriarca F; Reinoso-Segura M; Caballero-Velázquez T; Pérez-Simón JA;

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2022 Mar;22(3):407-421. doi: 10.1080/14712598.2021.1974394. Epub 2021 Sep 15.

2022
AOU Città della Salute di Torino

Moscato T; Irrera G; Console G; Ferreri A; Naso V; Sanguedolce C; Surace R; Pellicano' M; Pontari A; Loddo V; Rao CM; Scappatura G; Franzutti C; Curmaci F; Quattrone D; Moschella A; Gattuso C; Dattola V; Borzumati V; Morabito A; Florenzano MT; Amalfi V; Labate D; Germano' J; Alati C; Stelitano C; Imbalzano L; Russo L; Cusumano G; et alii...

The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Mar;57(3):384-390. doi: 10.1038/s41409-021-01493-6. Epub 2022 Jan 13.

2022
AOU Città della Salute di Torino

Shimoni A; Labopin M; Angelucci E; Blaise D; Ciceri F; Koc Y; Gülbas Z; Diez-Martin JL; Bruno B; Castagna L; Martino M; Rovira M; Mohty M; Nagler A;

Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Mar;28(3):169.e1-169.e9. doi: 10.1016/j.jtct.2021.12.014. Epub 2021 Dec 2

2022
AOU Città della Salute di Torino

Santoro A; Bruno B; Bramanti S; Mineri R; Tordato F; Valli V; Mannina D; Harbi S; Sarina B; Giaccone L; Faraci D; Maisano V; De Philippis C; Granata A; Richiardi L; Giordano L; Magri F; Furst S; Legrand F; Mariotti J; Devillier R; Blaise D; Castagna L;

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Jun;57(6):949-958. doi: 10.1038/s41409-022-01626-5. Epub 2022 Apr 12.

2022
AOU Alessandria
AOU Città della Salute di Torino

Oldani E; Vallisa D; Sacchi N; Vacca A; Tringali S; Parma M; Palazzo G; Onida F; Musso M; Grillo G; Casini M; Baronciani D; Nozzoli C; Cupri A; Luppi M; Chiusolo P; Carluccio P; Sorasio R; Santarone S; Proia A; Picardi A; Cilloni D; Carella AM; Di Grazia C; Brunello L; Patriarca F; Iori AP; Grassi A; Busca A; et alii...

ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications. in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis / Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221125785. doi: 10.1177/10760296221125785.

2022
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Massaia M; Bruno B; Borchiellini A; Porreca A; Montaruli B; Sivera P; Pizzo E; Valpreda A; Valeri F; Dainese C;

GITMO Registry Study on Allogeneic Transplantation in Patients Aged ?60 Years from 2000 to 2017: Improvements and Criticisms. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Feb;28(2):96.e1-96.e11. doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bonifazi F; Mammoliti S; Oldani E; Ciceri F; Russo D; Selleri C; Sacchi N; Borghero C; Proia A; Skert C; Carluccio P; Pavone V; Iori AP; Falcioni S; Luppi M; Mazza P; Bassi S; Onida F; Vacca A; Nozzoli C; Casini M; Carella AM; Terruzzi E; Olivieri A; Chiusolo P; De Gobbi M; Natale A; Bramanti S; Bernasconi P; et alii...

Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Feb;57(2):312-314. doi: 10.1038/s41409-021-01541-1. Epub 2021 Nov 30.

2022
AOU Città della Salute di Torino

Tassi V; Evangelista A; Francisci T; Cattel F; Leone S; Bringhen S; Cavallo F; Ferrero D; Massaia M; Lia G; Omedè P; Redoglia V; Cerrano M; Scaldaferri M; Londono JS; Brunello L; Giaccone L; Boccadoro M; Bruno B;

Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. in Journal of clinical medicine / J Clin Med. 2022 Dec 19;11(24):7542. doi: 10.3390/jcm11247542.

2022
AOU Città della Salute di Torino

Clerico M; Dogliotti I; Aroldi A; Consoli C; Giaccone L; Bruno B; Cavallo F;

Donor-derived acute myeloid leukemia in solid organ transplantation. in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons / Am J Transplant. 2022 Dec;22(12):3111-3119. doi: 10.1111/ajt.17174. Epub 2022 Sep 8.

2022
AOU Città della Salute di Torino

Gaidano G; Omar MN; Imada EL; Zanettini C; Berrino M; Stratta P; Besso FG; Deaglio S; Serra A; Kostadinov R; Lobo FP; Marchionni L; Bruno B; Saglio G; Amoroso A;

Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Dec;57(12):1758-1764. doi: 10.1038/s41409-022-01565-1. Epub 2022 Sep 3.

2022
AOU Città della Salute di Torino

Mavilio D; Blaise D; Bruno B; Bacigalupo A; Furst S; Santoro A; Chabannon C; Chiusolo P; Sica S; Frieri C; Marotta S; Marano L; Sperotto A; Fanin R; Console G; Loteta B; Savino L; Merla E; Brunello L; Giaccone L; Busca A; Risitano A; Martino M; Carella MA; Patriarca F; Harbi S; Evangelista A; Raiola AM; Mariotti J; et alii...

Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Apr;57(4):562-571. doi: 10.1038/s41409-022-01577-x. Epub 2022 Jan 25.

2022
AOU Città della Salute di Torino

Forcade E; Choi G; Corral LL; Tischer J; Martin H; Pavlu J; Arat M; Socié G; Nguyen S; Bulabois CE; Grillo G; Araujo MC; Martino M; Moiseev I; Rovira M; Bruno B; Castagna L; Sica S; Diez-Martin JL; Vitek A; Gülbas Z; Koc Y; Ruggeri A; Raiola AM; Blaise D; Labopin M; Galimard JE; Battipaglia G; McDonald A; et alii...

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Sep;56(9):2194-2202. doi: 10.1038/s41409-021-01317-7. Epub 2021 Apr 30.

2021
AOU Città della Salute di Torino

Brissot E; Ruggeri A; Sanz J; Diez-Martin JL; Blaise D; Benedetti F; Zuckerman T; Tischer J; Schmid C; Potter V; Kuball J; Caballero D; Brecht A; Angelucci E; Valerius T; Niittyvuopio R; Labussière-Wallet H; Gedde-Dahl T; Bornhäuser M; Bruno B; Finke J; Bazarbachi A; Ciceri F; Labopin M; Kharfan-Dabaja MA; Savani BN; Giebel S; Nagler A; Mohty M; et alii...

Legionellosis after hematopoietic stem cell transplantation. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Oct;56(10):2555-2566. doi: 10.1038/s41409-021-01333-7. Epub 2021 May 22

2021
AOU Città della Salute di Torino

Itälä-Remes M; Garcia CB; Bruno B; Blaise D; Veelken H; Michel G; Caillot D; Pioltelli P; Xhaard A; Passweg J; Labussière-Wallet H; Gil L; Yañez L; Hoek J; Tridello G; Mikulska M; Crawley C; Bourhis JH; Kaare A; Arcese W; Parody R; Styczynski J;

Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 May;27(5):406.e1-406.e11. doi: 10.1016/j.jtct.2020.11.021. Epub 2021 Feb

2021
AOU Città della Salute di Torino

Gallina AM; Patriarca F; Andreani M; Celeghini I; Carluccio P; Martino M; Olivieri A; Carella AM; Luppi M; Lamparelli T; Milone G; Papalinetti G; La Rocca U; Borghero C; Zallio F; Chiusolo P; Saporiti G; Guidi S; Fagioli F; Farina L; Russo D; Pioltelli P; Benedetti F; Bernasconi P; Arcese W; Vago L; Cerno M; Bruno B; Sessa M; et alii...

COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment. in HemaSphere / Hemasphere. 2021 Jun 12;5(7):e592. doi: 10.1097/HS9.0000000000000592. eCollection 2021 Jul.

2021
ASL Città di Torino
AOU Città della Salute di Torino

Rinaldi M; Cavallo R; Stroffolini G; Zanotto E; Barbero C; Ferrero S; Caracciolo D; Boffini M; Ragaini S; Leone S; Grimaldi D; Calcagno A; Dogliotti I; Clerico M; Bruno B; Cavallo F;

Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience. in Annals of hematology / Ann Hematol. 2021 Jul;100(7):1837-1847. doi: 10.1007/s00277-021-04521-z. Epub 2021 May 4.

2021
AOU Città della Salute di Torino

Busca A; Zallio F; Sorasio R; Mordini N; Vassallo S; Faraci DG; Dellacasa CM; Brunello L; Cerrano M; Butera S; Bruno B; Giaccone L;

Biomarkers for acute and chronic graft versus host disease: state of the art. in Expert review of hematology / Expert Rev Hematol. 2021 Jan;14(1):79-96. doi: 10.1080/17474086.2021.1860001. Epub 2020 Dec 24.

2021
AOU Città della Salute di Torino

Mavilio D; Brignardello E; Felicetti F; Mariotti J; Dellacasa C; Cerrano M; Gabrielli G; Di Vito C; Lia G; Butera S; Faraci DG; Giaccone L; Bruno B;

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Jan;56(1):20-29. doi: 10.1038/s41409-020-0974-6. Epub 2020 Jun 19.

2021
AOU Città della Salute di Torino

Savani BN; Finke J; Franke GN; Saccardi R; Ruggeri M; Mielke S; Socié G; La Nasa G; Pioltelli P; Rambaldi A; Bruno B; Labopin M; Dholaria B; Nagler A; Ruggeri A; Mohty M;

Impact of Allogeneic Stem Cell Transplantation on Testicular and Sexual Function. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 Feb;27(2):182.e1-182.e8. doi: 10.1016/j.jtct.2020.10.020. Epub 2020 Dec 1

2021
AOU Città della Salute di Torino

Bruno B; Lanfranco F; Arvat E; Ghigo E; Giaccone L; Cattel F; Motta G; Dionisi-Vici M; Busca A; Scaldaferri M; Dellacasa C; Faraci D; Felicetti F; Zavattaro M; Brignardello E;

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma. in Haematologica / Haematologica. 2021 Aug 1;106(8):2054-2065. doi: 10.3324/haematol.2020.276402.

2021
AOU Città della Salute di Torino

Bruno B; Wäsch R; Engelhardt M; Gay F; Giaccone L; D'Agostino M; Rodríguez-Lobato LG; Danhof S; Gagelmann N; Kröger N; Popat R; Van de Donk NWCJ; Terpos E; Dimopoulos MA; Sonneveld P; Einsele H; Boccadoro M;

Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Aug;56(8):1842-1849. doi: 10.1038/s41409-021-01248-3. Epub 2021 Mar 5.

2021
AOU Città della Salute di Torino

Martino M; Arat M; Bruno B; Castagna L; Gülbas Z; Diez-Martin JL; Koc Y; Chiusolo P; Ciceri F; Blaise D; Angelucci E; Labopin M; Ruggeri A; Nagler A; Mohty M;

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Apr 10;39(11):1223-1233. doi: 10.1200/JCO.20.01659. Epub 2021 Feb 4.

2021
AOU Città della Salute di Torino

Palomo L; Sole F; Kordasti S; Kern W; Rambaldi A; Bolli N; Ciceri F; Passamonti F; Remondini D; Giampieri E; Savevski V; Saitta C; Campagna A; Morabito L; Ubezio M; Riva M; Oliva E; Voso MT; Bacigalupo A; Santini V; Bonifazi F; Bruno B; Borin L; Bernardi M; Angelucci E; Termanini A; Maggioni G; Rossi M; Zampini M; et alii...

Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide. in Frontiers in immunology / Front Immunol. 2022 Jan 25;12:816231. doi: 10.3389/fimmu.2021.816231. eCollection 2021.

2021
AOU Città della Salute di Torino

Evangelista A; Castagna L; Boyle EM; Camussi G; Giaccone L; Fascì M; Comba L; Calvi M; Zaghi E; Bramanti S; Mariotti J; Santoro A; Brunello L; Tapparo M; Bruno S; Di Vito C; Lia G; Mavilio D; Bruno B;

Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role? in Frontiers in immunology / Front Immunol. 2021 May 19;12:641427. doi: 10.3389/fimmu.2021.641427. eCollection 2021.

2021
AOU Città della Salute di Torino

Bruno B; Leone S; Giaccone L; Lia G;

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience. in Frontiers in oncology / Front Oncol. 2021 Sep 6;11:740079. doi: 10.3389/fonc.2021.740079. eCollection 2021.

2021
AOU Città della Salute di Torino

Pugliese M; Canale FA; Selleri C; Attolico I; Musto P; Mazza P; Marotta S; Di Renzo N; Scalone R; Musso M; Busca A; Giaccone L; Merla E; Colasante F; Ferreri A; Prezioso L; Loteta B; Cimminiello M; Leotta S; Storti G; Mordini N; Serio B; Vacca A; Paviglianiti A; Musuraca G; Pastore D; Carluccio P; Ingrosso C; Tringali S; et alii...

Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. in Frontiers in immunology / Front Immunol. 2021 Dec 21;12:813838. doi: 10.3389/fimmu.2021.813838. eCollection 2021.

2021
AOU Città della Salute di Torino

Kröger N; Lee SJ; Hayden P; Schaap N; Ljungman P; Potter V; Massalski C; Lange V; Onida F; Bruno B; van Gelder M; Spellman S; de Wreede LC; Heidenreich F; Kuxhausen M; Koster L; Schetelig J; Baldauf H; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M;

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...

Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. in Annals of hematology / Ann Hematol. 2020 Sep;99(9):2197-2199. doi: 10.1007/s00277-020-04180-6. Epub 2020 Jul 13.